| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 35.06% | Rosenblatt | $70 → $47 | Maintains | Buy |
| 10/24/2023 | 152.87% | Needham | → $88 | Reiterates | Buy → Buy |
| 10/13/2023 | 101.15% | Rosenblatt | → $70 | Reiterates | Buy → Buy |
| 08/25/2023 | 101.15% | Rosenblatt | → $70 | Reiterates | Buy → Buy |
| 07/21/2023 | 101.15% | Rosenblatt | → $70 | Reiterates | Buy → Buy |
| 07/21/2023 | 152.87% | Needham | → $88 | Reiterates | Buy → Buy |
| 07/20/2023 | 101.15% | Rosenblatt | → $70 | Reinstates | Buy → Buy |
| 07/20/2023 | 152.87% | Needham | → $88 | Reiterates | Buy → Buy |
| 07/18/2023 | 109.77% | Roth MKM | → $73 | Reiterates | Buy → Buy |
| 07/18/2023 | 101.15% | Rosenblatt | → $70 | Reiterates | Buy → Buy |
| 06/09/2023 | 101.15% | Rosenblatt | → $70 | Reiterates | Buy → Buy |
| 05/19/2023 | 152.87% | Needham | → $88 | Reiterates | Buy → Buy |
| 05/19/2023 | 40.8% | JP Morgan | → $49 | Initiates Coverage On | → Neutral |
| 04/24/2023 | 152.87% | Needham | → $88 | Reiterates | → Buy |
| 04/21/2023 | 127.01% | TD Cowen | $78 → $79 | Maintains | Outperform |
| 04/21/2023 | 101.15% | Rosenblatt | $75 → $70 | Maintains | Buy |
| 04/21/2023 | 109.77% | Roth MKM | $74 → $73 | Maintains | Buy |
| 04/20/2023 | 115.52% | Rosenblatt | → $75 | Reiterates | → Buy |
| 04/20/2023 | 152.87% | Needham | → $88 | Reiterates | → Buy |
| 02/06/2023 | 115.52% | Rosenblatt | $85 → $75 | Maintains | Buy |
| 01/27/2023 | 152.87% | Loop Capital | $83 → $88 | Maintains | Buy |
| 01/27/2023 | 129.89% | Northland Capital Markets | $85 → $80 | Maintains | Outperform |
| 12/22/2022 | 152.87% | Needham | $82 → $88 | Maintains | Buy |
| 10/26/2022 | 144.25% | Rosenblatt | $75 → $85 | Maintains | Buy |
| 10/26/2022 | 135.63% | Needham | $70 → $82 | Maintains | Buy |
| 10/18/2022 | 101.15% | Needham | $63 → $70 | Maintains | Buy |
| 10/12/2022 | 115.52% | Rosenblatt | $65 → $75 | Maintains | Buy |
| 07/27/2022 | 104.02% | Cowen & Co. | $48 → $71 | Maintains | Outperform |
| 07/27/2022 | 86.78% | Rosenblatt | $60 → $65 | Maintains | Buy |
| 07/27/2022 | 81.03% | Needham | $60 → $63 | Maintains | Buy |
| 07/27/2022 | 92.53% | Barrington Research | $63 → $67 | Maintains | Outperform |
| 06/22/2022 | 75.29% | Jefferies | $69 → $61 | Maintains | Buy |
| 04/27/2022 | 72.41% | Needham | $73 → $60 | Maintains | Buy |
| 04/12/2022 | 72.41% | Rosenblatt | → $60 | Initiates Coverage On | → Buy |
| 04/07/2022 | 29.31% | Northland Capital Markets | → $45 | Upgrades | Market Perform → Outperform |
| 02/23/2022 | 101.15% | Loop Capital | → $70 | Initiates Coverage On | → Buy |
| 01/28/2022 | 58.05% | Craig-Hallum | → $55 | Upgrades | Hold → Buy |
| 10/27/2021 | 109.77% | Needham | $55 → $73 | Maintains | Buy |
| 07/27/2021 | 58.05% | Needham | $50 → $55 | Maintains | Buy |
| 07/23/2021 | 66.67% | Barrington Research | → $58 | Initiates Coverage On | → Outperform |
| 06/22/2021 | 43.68% | Needham | → $50 | Initiates Coverage On | → Buy |
| 03/29/2021 | -62.64% | BWS Financial | → $13 | Initiates Coverage On | → Sell |
| 01/29/2021 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 10/22/2020 | 0.57% | Jefferies | $30 → $35 | Maintains | Buy |
| 10/14/2020 | -28.16% | Needham | → $25 | Initiates Coverage On | → Buy |
| 04/24/2020 | -62.64% | Jefferies | $7 → $13 | Upgrades | Hold → Buy |
| 11/06/2018 | -59.77% | Cowen & Co. | $6 → $14 | Upgrades | Market Perform → Outperform |
What is the target price for Calix (CALX)?
The latest price target for Calix (NYSE: CALX) was reported by Rosenblatt on October 25, 2023. The analyst firm set a price target for $47.00 expecting CALX to rise to within 12 months (a possible 35.06% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Calix (CALX)?
The latest analyst rating for Calix (NYSE: CALX) was provided by Rosenblatt, and Calix maintained their buy rating.
When is the next analyst rating going to be posted or updated for Calix (CALX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calix was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Calix (CALX) correct?
While ratings are subjective and will change, the latest Calix (CALX) rating was a maintained with a price target of $70.00 to $47.00. The current price Calix (CALX) is trading at is $34.80, which is out of the analyst's predicted range.